×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ARRY – array technologies, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ARRY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/15
08:43 am
arry
Array Technologies, Inc. (ARRY): A Bull Case Theory [Yahoo! Finance]
Medium
Report
Array Technologies, Inc. (ARRY): A Bull Case Theory [Yahoo! Finance]
1/14
07:36 pm
arry
Array Technologies, Inc. (ARRY) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]
Medium
Report
Array Technologies, Inc. (ARRY) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]
1/13
07:07 pm
arry
Is Array Technologies (ARRY) Outperforming Other Oils-Energy Stocks This Year? [Yahoo! Finance]
Medium
Report
Is Array Technologies (ARRY) Outperforming Other Oils-Energy Stocks This Year? [Yahoo! Finance]
1/9
07:38 pm
arry
Why Analysts Say Array Technologies (ARRY) Story Is Shifting With New Targets And Guidance [Yahoo! Finance]
High
Report
Why Analysts Say Array Technologies (ARRY) Story Is Shifting With New Targets And Guidance [Yahoo! Finance]
1/9
07:03 pm
arry
Does Array Technologies' (ARRY) New Commercial Leadership Signal a Deeper Shift in Its Turnaround Strategy? [Yahoo! Finance]
High
Report
Does Array Technologies' (ARRY) New Commercial Leadership Signal a Deeper Shift in Its Turnaround Strategy? [Yahoo! Finance]
1/9
12:37 am
arry
Is Array Technologies (ARRY) Offering An Opportunity After Mixed Multi-Year Share Price Moves [Yahoo! Finance]
Low
Report
Is Array Technologies (ARRY) Offering An Opportunity After Mixed Multi-Year Share Price Moves [Yahoo! Finance]
1/8
06:41 am
arry
Best Value Stocks to Buy for January 8th [Yahoo! Finance]
Low
Report
Best Value Stocks to Buy for January 8th [Yahoo! Finance]
1/6
09:00 am
arry
ARRAY Technologies Promotes Darin Green to Global Chief Revenue Officer and Nick Strevel to Chief Product Officer
Medium
Report
ARRAY Technologies Promotes Darin Green to Global Chief Revenue Officer and Nick Strevel to Chief Product Officer
Date
Time
Symbol
Company Name
Action
%Chg
2/27/2025
04:05 pm
ARRY
array technologies, inc.
IN-LINE
Report
-19.7%
array technologies, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/3
11:13 am
arry
Form SCHEDULE 13G/A Array Technologies, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Array Technologies, Inc. Filed by: VANGUARD GROUP INC
11/7
12:27 pm
arry
Form SCHEDULE 13G Array Technologies, Inc. Filed by: MORGAN STANLEY
Low
Report
Form SCHEDULE 13G Array Technologies, Inc. Filed by: MORGAN STANLEY
11/5
05:17 pm
arry
Form 10-Q Array Technologies, Inc. For: Sep 30
Medium
Report
Form 10-Q Array Technologies, Inc. For: Sep 30
11/5
04:09 pm
arry
Form 8-K Array Technologies, Inc. For: Nov 05
Low
Report
Form 8-K Array Technologies, Inc. For: Nov 05
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
5/21
Array BioPharma's colorectal cancer combo treatment meets main goals [Reuters (UK)]
28.9%
5/29 Array BioPharma to Present at the Jefferies 2019 Global Healthcare Conference 4.5%
6/3 Form 4 ARRAY BIOPHARMA INC For: May 30 Filed by: Sandor Victor 2.8%
5/23 Form 4 ARRAY BIOPHARMA INC For: May 21 Filed by: Sandor Victor 2.6%
5/7 Array BioPharma Inc. (ARRY) CEO Ron Squarer on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 2.3%
5/10 Array Biopharma Inc (NASDAQ: ARRY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $25.00 price target on the stock. 0.8%
7/25 Form SC 14D9/A ARRAY BIOPHARMA INC Filed by: ARRAY BIOPHARMA INC 0.8%
6/4 Array BioPharma to Present at the Goldman Sachs 40?? Annual Global Healthcare Conference 0.7%
7/29 Form SC TO-T/A ARRAY BIOPHARMA INC Filed by: PFIZER INC 0.7%
6/28 Form SC TO-T ARRAY BIOPHARMA INC Filed by: PFIZER INC 0.7%
5/29 Array BioPharma to Present at the Jefferies 2019 Global Healthcare Conference 4.5%
6/3 Form 4 ARRAY BIOPHARMA INC For: May 30 Filed by: Sandor Victor 2.8%
5/23 Form 4 ARRAY BIOPHARMA INC For: May 21 Filed by: Sandor Victor 2.6%
5/7 Array BioPharma Inc. (ARRY) CEO Ron Squarer on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 2.3%
5/10 Array Biopharma Inc (NASDAQ: ARRY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $25.00 price target on the stock. 0.8%
7/25 Form SC 14D9/A ARRAY BIOPHARMA INC Filed by: ARRAY BIOPHARMA INC 0.8%
6/4 Array BioPharma to Present at the Goldman Sachs 40?? Annual Global Healthcare Conference 0.7%
7/29 Form SC TO-T/A ARRAY BIOPHARMA INC Filed by: PFIZER INC 0.7%
6/28 Form SC TO-T ARRAY BIOPHARMA INC Filed by: PFIZER INC 0.7%
TOP News Decliners
5/7
Form 10-Q ARRAY BIOPHARMA INC For: Mar 31
-4.8%
5/28 Form 4 ARRAY BIOPHARMA INC For: May 23 Filed by: Sandor Victor -3.2%
6/17 Pfizer to Acquire Array BioPharma -2.1%
5/22 Array Biopharma Inc (NASDAQ: ARRY) had its price target raised by analysts at SunTrust Banks, Inc. to $32.00. They now have a "buy" rating on the stock. -1.4%
5/9 Array BioPharma to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference -1.0%
6/21 Financialbuzz.com: 'Market Recap' Week Ending June 21st, 2019 -0.6%
7/12 Array Biopharma Inc (NASDAQ: ARRY) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. -0.6%
6/18 Form SC TO-C ARRAY BIOPHARMA INC Filed by: PFIZER INC -0.6%
5/5 Array Biopharma Inc (NASDAQ: ARRY) was given a new $25.00 price target on by analysts at Cowen Inc. They now have a "buy" rating on the stock. -0.6%
7/12 Form SC 14D9/A ARRAY BIOPHARMA INC Filed by: ARRAY BIOPHARMA INC -0.5%
5/28 Form 4 ARRAY BIOPHARMA INC For: May 23 Filed by: Sandor Victor -3.2%
6/17 Pfizer to Acquire Array BioPharma -2.1%
5/22 Array Biopharma Inc (NASDAQ: ARRY) had its price target raised by analysts at SunTrust Banks, Inc. to $32.00. They now have a "buy" rating on the stock. -1.4%
5/9 Array BioPharma to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference -1.0%
6/21 Financialbuzz.com: 'Market Recap' Week Ending June 21st, 2019 -0.6%
7/12 Array Biopharma Inc (NASDAQ: ARRY) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. -0.6%
6/18 Form SC TO-C ARRAY BIOPHARMA INC Filed by: PFIZER INC -0.6%
5/5 Array Biopharma Inc (NASDAQ: ARRY) was given a new $25.00 price target on by analysts at Cowen Inc. They now have a "buy" rating on the stock. -0.6%
7/12 Form SC 14D9/A ARRAY BIOPHARMA INC Filed by: ARRAY BIOPHARMA INC -0.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: